NCT03250078View on ClinicalTrials.gov

A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Pancreatic Neoplasms
Interventions
DIAGNOSTIC_TEST

MRI/MRCP

An MRI/MRCP plus IV gadolinium contrast with high resolution imaging of the pancreas will be performed annually

Trial Locations (1)

06856

RECRUITING

Nuvance Health, Norwalk

Sponsors

Lead Sponsor

Nuvance Health
All Listed Sponsors
lead

Nuvance Health

OTHER

NCT03250078 - A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals | Biotech Hunter | Biotech Hunter